Sclerodermatous graft-versus-host disease after donor leucocyte infusion

British Journal of Dermatology

Volumn 139, Issue 5, 1998, Pages 889-892

  Jones Caballero, M ^b   Fernandez Herrera J ^a   Cordoba Guijarro S ^a   Dauden Tello E ^a   Garcia Diez A ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b Ambulatorio Hermanos Sangro ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DISEASE COURSE; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA; MALE; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SCLERODERMA; SKIN BIOPSY;

ADULT; GRAFT VS HOST DISEASE; HUMANS; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; LEUKOCYTE TRANSFUSION; MALE; SCLERODERMA, SYSTEMIC;

EID: 0031797845     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.02520.x     Document Type: Article

References (17)

1. Chosidow O, Bagot M, Vernant JP et al. Sclerodermatous chronic graft-versus-host disease. Analysis of seven cases. J Am Acad Dermatol 1992; 26: 49-55.
2. Porter DL, Antin JH. Adoptive immunotherapy in hone marrow transplantation. In: Graft-vs-Host Disease (Ferrara JLM, Deeg HJ, Burakoff SJ, eds), 2nd edn. New York: Marcel Dekker Inc., 1997; 753-54.
3. Truitt RL, Johnson BK, McCahe CM, Weiler MB. Graft versus leukemia. In: Graft-vs-Host Disease (Ferrara JLM, Deeg HJ, Burakoff SJ, eds), 2nd edn. New York: Marcel Dekker Inc., 1997; 385-423.
4. Drobyski WR, Keever CA, Roth MS et al. Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose. Blood 1993; 82: 2310-18.
5. Porter DL, Roth MS, McGarigle C et al. Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. N Engl J Med 1994; 330: 100-6.
6. van Rhee F, Lin F, Cullis JO et al. Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood 1994; 83: 3377-88.
7. Kolb HJ, Schattenberg A, Goldman JM et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995; 86: 2041-50.
8. Bär BM, Schattemberg A, Mensink EJ et al. Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation. J Clin Oncol 1993; 11: 513-19.
9. Mackinnon S, Papadopoulos E, Carabasi M et al. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapses of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host-disease. Blood 1995; 86: 1261-8.
10. Peǹas PF, Jones-Caballero M, Fraga J et al. Generalized sclerodermiform type of graft-versus-host-disease. J Eur Acad Dermatol Venereol 1995; 5: S71-2.
11. Janin-Mercier J, Saurat JH, Bourges M et al. The lichen planus like and sclerotic phases of the graft versus host disease in man: an ultrastructural study of six cases. Acta Derm Venereol (Stockh) 1981; 61: 187-93.
12. Heney D, Norfolk DR, Wheeldon J et al. Thalidomide treatment for chronic graft-versus-host disease. Br J Haematol 1991; 78: 23-7.
13. Ringdén O. Clinical spectrum of graft-versus-host-disease. In: Graft-vs-host Disease (Ferrara JLM, Deeg HJ, Burakoff SJ, eds), 2nd edn. New York: Marcel Dekker Inc., 1997; 525-59.
14. Hertenstein B, Wiesneth M, Novotny J et al. Interferon-alfa and donor buffy coat transfusions for treatment of relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation. Blood 1993; 56: 1114-18.
15. Bonini C, Ferrari G, Verzeletti S et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 1997; 27: 1719-24.
16. Artlett CM, Smith JB, Jimenez SA. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med 1998; 338: 1186-91.
17. Valks R, Fraga J, Porras-Luque F et al. Chemotherapy-induced eccrine squamous syringometaplasia. Arch Dermatol 1997; 133: 873-8.